New drug tested for tough blood cancers in older adults
NCT ID NCT02438761
Summary
This study tested an experimental drug called PF-05212384 for people with aggressive forms of blood cancer, including acute myeloid leukemia (AML) that had returned or didn't respond to other treatments, or AML that developed as a side effect of prior cancer therapy. The goal was to see if the drug could control the disease. The trial was small and ended early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Toulouse
Toulouse, Midi-Pyrénées, 31059, France
-
Hôpital Cochin
Paris, Île-de-France Region, 75679, France
-
Hôpital Saint-Louis
Paris, Île-de-France Region, 75475, France
-
Institut Curie - Hôpital René Huguenin
Saint-Cloud, Île-de-France Region, 92210, France
-
Institut Paoli Calmette
Marseille, PACA, 13009, France
Conditions
Explore the condition pages connected to this study.